Potential Success Of Experimental Ebola Vaccine Could Quickly End Future Outbreaks, Associated Fear

Politico: How to Eradicate Political Panic
Joanne Kenen, Politico’s health care editor

“…The [experimental Ebola] vaccine, if successful, would be distinctive, since it wouldn’t require global vaccination programs, as have efforts to eradicate diseases like polio. Instead, the trial vaccines rely on what’s known as the ‘ring method,’ creating a circle around the virus to contain it. Doctors, nurses, community health workers, and other first responders would be vaccinated widely and routinely, protecting them before any outbreaks emerge. Vaccines could be deployed swiftly once a case is detected and before a full-scale outbreak explodes. If the work proves successful in the months and years ahead, the world may never again know the fear that gripped us in 2014…” (9/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.